Infliximab treatment for refractory COVID-19-associated multisystem inflammatory syndrome in a Japanese child

Patients with multisystem inflammatory syndrome in children (MIS-C) can develop clinical features resembling Kawasaki disease (KD). A full picture of MIS-C in East Asia which has higher incidence of KD than other regions remains unclear. We report on a 15-year-old Japanese boy with refractory MIS-C...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamaguchi, Yohei, Takasawa, Kei, Irabu, Hitoshi, Hiratoko, Kanako, Ichigi, Yosuke, Hirata, Ko, Tamura, Yumie, Murakoshi, Miki, Yamashita, Motoi, Nakatani, Hisae, Shimoda, Masuhiro, Ishii, Taku, Udagawa, Tomohiro, Shimizu, Masaki, Kanegane, Hirokazu, Morio, Tomohiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784439/
https://www.ncbi.nlm.nih.gov/pubmed/35125343
http://dx.doi.org/10.1016/j.jiac.2022.01.011

Ejemplares similares

Ejemplares similares